Compound 5e, a GPR34 receptor antagonist, exhibits selective inhibition of lysophosphatidylserine-induced ERK1/2 phosphorylation in a dose-dependent manner, demonstrating an IC50 value of 0.680 µM without significant cytotoxicity. Additionally, it displa
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted